Despina Asouchidou

Despina Asouchidou

Auto-generated profile, based on publicly available information

Despina Asouchidou

Department of Immunology, National Peripheral Histocompatibility Center, Hippokration Hospital, Thessaloniki, Greece

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2023 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
GLGeorge Lioulios
George Lioulios
AFAsimina Fylaktou
Asimina Fylaktou
DADespina Asouchidou
Despina Asouchidou
AXAliki Xochelli
Aliki Xochelli
VNVasiliki Nikolaidou
Vasiliki Nikolaidou
MSMaria Stangou
Maria Stangou
Background: The response to vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) varies depending on comorbidities. This study evaluated the clinical and immunological factors affecting the humoral response of patients with end stage renal disease (ESRD) to the BNT162b2 vaccine. Methods: Humoral immunity was evaluated in 54 ESRD patients using serum levels of anti-receptor-binding domain (RBD) and neutralizing antibodies (NAbs), measured by chemiluminescent immunoassay 30 (T1), 60 (T2), and 120 (T3) days after the second vaccine dose. The results were correlated to baseline patient T-and B-lymphocyte sub populations determined by flow cytometry. Results: The proportion of seroconverted patients based on the NAb titer decreased from 83.3% at tau 1 to 53.7% at tau 3. Age was negatively correlated to the NAb titer at T1 and tau 2. Patients receiving hemodiafiltration had higher NAb titers at T3. Diabetes was associated with a lower response rate at T3. Univariate analysis revealed a positive correlation be-tween the naive CD4 T-lymphocyte population and RBD titer at T1 and the NAb titer at T3, with no association observed with naive CD8 T lymphocytes. NAb titers at T3 were significantly correlated with late-differentiated CD4 T lymphocytes and terminally differen-tiated effector memory cells re-expressing CD45RA (TEMRA) CD8 T lymphocytes. RBD levels were positively correlated with naive and memory B-lymphocyte counts at T3. Conclusions: Age, diabetes, and hemodialysis prescription had significant impacts on the response to vaccination. T-and B-lymphocyte phenotypes are major determinants of the humoral response potency to SARS-CoV-2 vaccination with BNT162b2 in patients with ESRD.